Jump Financial, LLC Lantern Pharma Inc. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.42 - $4.83 $44,118 - $62,307	-12,900 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$3.91 - $9.51 $50,439 - $122,679	12,900 New	12,900 $60,000
Q1 2022 May 12, 2022	SELL	$5.6 - $8.22 $61,756 - $90,650	-11,028 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$7.11 - $11.04 $78,409 - $121,749	11,028 New	11,028 $88,000

1.31M

39.8K

6.1K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $37M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.